[DeNuo Honor] DeNuo Capital was awarded the "Top 10 Most Potential Investment Institutions in Biomed On August 4, 2022, the sixth China Biomedical Innovation and Cooperation Conference and the 2022 China Biomedical Industry Value List Award Ceremony officially opened, at which the 2022 China Biomedical Industry Value List was released. DeNuo Capital was awarded the "Top 10 Most Potential Investment Institutions in the Biomedical Industry". In addition, DeNuo Capital's investment ...

Denau Family | Foundation of Binhui Biological Tumor Immunotherapy Drug Industry Base On October 8, 2022, the foundation laying ceremony of the tumor immunotherapy drug industrial base of Wuhan Binhui Biotechnology Co., Ltd. (hereinafter referred to as Binhui Biotechnology), an invested enterprise of Denuo Capital, was held in Wuhan Optics Valley Biological City Medical Park.On October 8, 2022, the foundation laying ceremony of Binhui Biological Tumor Immunotherapy Drug Industry...

DeNuo Capital Investment Project: Qiming Medical received guidance on listing, mainly guiding releva On March 13, Zhejiang Regulatory Bureau of China Securities Regulatory Commission (CSRC) disclosed the guidance filing publicity document of Denuo Capital Investment Project - Hangzhou Qiming Medical Devices Co., Ltd. (hereinafter referred to as "Qiming Medical"), which requires guidance on relevant regulations of scientific innovation version.As a company specializing in providing hi...

Dinova Capital Website Launched After careful planning and preparation, the enterprise website of Dinova Capital was officially launched. Through this website, you can get the latest product information and news information of our company more quickly.Thanks for the strong support of new and old customers for Dinova Capital, and we will continue to work hard to provide you with better service with excellent product quality an...